Improving outcomes after acute coronary events: what works and what doesn't

Eur Heart J. 2018 Aug 1;39(29):2691-2694. doi: 10.1093/eurheartj/ehy499.

Author

Thomas F Lüscher^{1

2

3}

Affiliations

¹ Consultant and Director of Research, Education & Development, Royal Brompton and Harefield Hospital Trust, London, UK.
² Chairman, Center for Molecular Cardiology, University of Zurich, Switzerland.
³ EHJ Editorial Office, Zurich Heart House, Hottingerstreet 14, Zurich, Switzerland.

PMID: 30289521
DOI: 10.1093/eurheartj/ehy499

No abstract available

Publication types

Introductory Journal Article

MeSH terms

Acute Coronary Syndrome / blood
Acute Coronary Syndrome / drug therapy
Blood Glucose
Cardiovascular Diseases / diagnosis*
Cardiovascular Diseases / therapy*
Humans
Nitric Oxide / therapeutic use*
Oxygen Inhalation Therapy*
Platelet Aggregation Inhibitors / therapeutic use*
RNA, Untranslated*
ST Elevation Myocardial Infarction / therapy

Substances

Blood Glucose
Platelet Aggregation Inhibitors
RNA, Untranslated
Nitric Oxide